Head-to-head · WeighScore
Layla vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 70.9/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.
Before you choose
Layla does not publish a semaglutide price, so its Layla review sets out what it does disclose, while the Vitara RX review explains the conditions attached to Vitara RX's figure. The semaglutide cost page compares published rates across the field. Ask Layla for a written total before treating either one as the cheaper choice.
If neither one fits, Layla vs Wisp and Lean Rx vs Vitara RX compare each of them with another graded program, and the list of alternatives to Layla ranks the programs closest to Layla on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the bmiMD review covers one graded close to these two, at 79.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Layla | Vitara RX |
|---|---|---|
| WeighScore | 70.9/100 | 86/100 |
| Grade | C | B |
| Site position | #108 | #10 |
| Semaglutide | Confirm selected offer and renewal | Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge. |
| Tirzepatide | Confirm selected offer and renewal | Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge. |
| Coverage | Coverage not published | Site lists 49 states, Alaska omitted; confirm medication-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes monthly and quarterly promotional options
What to consider
- The page displays multiple prices for each drug
- Support asks for 30 days’ notice to cancel a subscription
Strengths
- Named compounded semaglutide and tirzepatide offerings
- Ongoing provider messaging advertised
- Terms allow directing prescriptions to another pharmacy
What to consider
- Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
- FAQ, terms and returns pages cited earlier no longer load
- Published list omitted Alaska
- Refrigeration instructions conflict with the returns policy
- No universal lab schedule or testing price established
- Website policy descriptions leave clinical and dispensing roles unclear
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.